BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 31529263)

  • 1. Osteosarcoma in the Post Genome Era: Preclinical Models and Approaches to Identify Tractable Therapeutic Targets.
    Castillo-Tandazo W; Mutsaers AJ; Walkley CR
    Curr Osteoporos Rep; 2019 Oct; 17(5):343-352. PubMed ID: 31529263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine models of osteosarcoma: A piece of the translational puzzle.
    Walia MK; Castillo-Tandazo W; Mutsaers AJ; Martin TJ; Walkley CR
    J Cell Biochem; 2018 Jun; 119(6):4241-4250. PubMed ID: 29236321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach.
    Schott CR; Koehne AL; Sayles LC; Young EP; Luck C; Yu K; Lee AG; Breese MR; Leung SG; Xu H; Shah AT; Liu HY; Spillinger A; Behroozfard IH; Marini KD; Dinh PT; Pons Ventura MV; Vanderboon EN; Hazard FK; Cho SJ; Avedian RS; Mohler DG; Zimel M; Wustrack R; Curtis C; Sirota M; Sweet-Cordero EA
    Clin Cancer Res; 2024 Feb; 30(4):849-864. PubMed ID: 37703185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
    Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
    BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline and somatic genetics of osteosarcoma - connecting aetiology, biology and therapy.
    Gianferante DM; Mirabello L; Savage SA
    Nat Rev Endocrinol; 2017 Aug; 13(8):480-491. PubMed ID: 28338660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic Complexity of Osteosarcoma and Its Implication for Preclinical and Clinical Targeted Therapies.
    Schott C; Shah AT; Sweet-Cordero EA
    Adv Exp Med Biol; 2020; 1258():1-19. PubMed ID: 32767231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics of osteosarcoma.
    Bernardini G; Laschi M; Geminiani M; Santucci A
    Expert Rev Proteomics; 2014 Jun; 11(3):331-43. PubMed ID: 24654989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and targeting insulin growth factor receptor type 2 (IGF2R) in osteosarcoma PDX in mouse models and in canine osteosarcoma tumors.
    Karkare S; Allen KJH; Jiao R; Malo ME; Dawicki W; Helal M; Godson DL; Dickinson R; MacDonald-Dickinson V; Yang R; Hoang B; Gorlick R; Geller DS; Dadachova E
    Sci Rep; 2019 Aug; 9(1):11476. PubMed ID: 31391495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canine and murine models of osteosarcoma.
    Beck J; Ren L; Huang S; Berger E; Bardales K; Mannheimer J; Mazcko C; LeBlanc A
    Vet Pathol; 2022 May; 59(3):399-414. PubMed ID: 35341404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs for osteosarcoma in the mouse: a meta-analysis.
    Chang J; Yao M; Li Y; Zhao D; Hu S; Cui X; Liu G; Shi Q; Wang Y; Yang Y
    Oncotarget; 2016 Dec; 7(51):85650-85674. PubMed ID: 27852052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and characterization of patient-derived xenografts from patients with osteosarcoma.
    Chen F; Zhang Z; Shen R; Chen M; Li G; Zhu X
    Tissue Cell; 2022 Dec; 79():101911. PubMed ID: 36156374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma.
    Landuzzi L; Manara MC; Lollini PL; Scotlandi K
    Cells; 2021 Feb; 10(2):. PubMed ID: 33671173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of Patient-Derived Xenograft Mouse Model with Human Osteosarcoma Tissues.
    Sun X; Chang J; Zhou C; Zhao P; Guo S; Tong J; Wang Y; Yang Y
    J Vis Exp; 2024 Mar; (205):. PubMed ID: 38587398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart.
    Angstadt AY; Motsinger-Reif A; Thomas R; Kisseberth WC; Guillermo Couto C; Duval DL; Nielsen DM; Modiano JF; Breen M
    Genes Chromosomes Cancer; 2011 Nov; 50(11):859-74. PubMed ID: 21837709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterotypic mouse models of canine osteosarcoma recapitulate tumor heterogeneity and biological behavior.
    Scott MC; Tomiyasu H; Garbe JR; Cornax I; Amaya C; O'Sullivan MG; Subramanian S; Bryan BA; Modiano JF
    Dis Model Mech; 2016 Dec; 9(12):1435-1444. PubMed ID: 27874835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-species genomics identifies DLG2 as a tumor suppressor in osteosarcoma.
    Shao YW; Wood GA; Lu J; Tang QL; Liu J; Molyneux S; Chen Y; Fang H; Adissu H; McKee T; Waterhouse P; Khokha R
    Oncogene; 2019 Jan; 38(2):291-298. PubMed ID: 30093633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary.
    Gorlick R; Anderson P; Andrulis I; Arndt C; Beardsley GP; Bernstein M; Bridge J; Cheung NK; Dome JS; Ebb D; Gardner T; Gebhardt M; Grier H; Hansen M; Healey J; Helman L; Hock J; Houghton J; Houghton P; Huvos A; Khanna C; Kieran M; Kleinerman E; Ladanyi M; Lau C; Malkin D; Marina N; Meltzer P; Meyers P; Schofield D; Schwartz C; Smith MA; Toretsky J; Tsokos M; Wexler L; Wigginton J; Withrow S; Schoenfeldt M; Anderson B
    Clin Cancer Res; 2003 Nov; 9(15):5442-53. PubMed ID: 14654523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canine osteosarcoma genome sequencing identifies recurrent mutations in
    Gardner HL; Sivaprakasam K; Briones N; Zismann V; Perdigones N; Drenner K; Facista S; Richholt R; Liang W; Aldrich J; Trent JM; Shields PG; Robinson N; Johnson J; Lana S; Houghton P; Fenger J; Lorch G; Janeway KA; London CA; Hendricks WPD
    Commun Biol; 2019; 2():266. PubMed ID: 31341965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of CXCR7 inhibits proliferation and invasion of osteosarcoma cells through inhibition of the PI3K/Akt and β-arrestin pathways.
    Zhang Y; Yang CQ; Gao Y; Wang C; Zhang CL; Zhou XH
    Oncol Rep; 2014 Sep; 32(3):965-72. PubMed ID: 24969680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.
    Fenger JM; London CA; Kisseberth WC
    ILAR J; 2014; 55(1):69-85. PubMed ID: 24936031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.